MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
BioSig Technologies Retained Earnings 2011-2026 | BSGM
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings BioSig Technologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -255 M | -245 M | -216 M | -189 M | -157 M | -105 M | -70.7 M | -56.5 M | -43.8 M | -32.2 M | -22.8 M | -14 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -14 M | -255 M | -117 M |
Quarterly Retained Earnings BioSig Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -294 M | -279 M | -258 M | -255 M | -254 M | -252 M | -248 M | -245 M | -239 M | -234 M | -223 M | -216 M | -209 M | -203 M | -197 M | -189 M | -180 M | -173 M | -165 M | -157 M | -157 M | -157 M | -157 M | -105 M | -105 M | -105 M | -105 M | -70.7 M | -70.7 M | -70.7 M | -70.7 M | -56.5 M | -56.5 M | -56.5 M | -56.5 M | -43.8 M | -43.8 M | -43.8 M | -43.8 M | -32.2 M | -32.2 M | -32.2 M | -32.2 M | -22.8 M | -22.8 M | -22.8 M | -22.8 M | -14 M | -14 M | -14 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -14 M | -294 M | -126 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |
 |
Insulet Corporation
PODD
|
287 M | $ 215.63 | -4.38 % | $ 15.2 B | USA |
 |
Profound Medical Corp.
PROF
|
-130 M | $ 5.78 | 12.23 % | $ 180 M |  Canada |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Quanterix Corporation
QTRX
|
-577 M | $ 3.92 | 2.62 % | $ 167 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 9.54 | - | $ 735 M | USA |
 |
AVITA Medical
RCEL
|
-408 M | $ 3.97 | 3.39 % | $ 111 M |  Australia |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
-79 M | $ 1.33 | -1.48 % | $ 21.5 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Sintx Technologies
SINT
|
-292 M | $ 2.55 | -0.77 % | $ 7.07 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 36.9 | 0.86 % | $ 1.15 B | USA |
 |
Smith & Nephew plc
SNN
|
4.96 B | $ 32.43 | 0.82 % | $ 23.8 B |  Britain |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
-69.8 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 24.73 | 0.12 % | $ 209 M | USA |
 |
Sensus Healthcare
SRTS
|
5.72 M | $ 4.21 | 6.31 % | $ 68.7 M | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M | Canada |
 |
Tactile Systems Technology
TCMD
|
54.9 M | $ 26.86 | -0.02 % | $ 614 M | USA |
 |
TELA Bio
TELA
|
-321 M | $ 0.7 | -7.88 % | $ 16 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.67 | -3.33 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
-168 M | $ 2.38 | 10.12 % | $ 3.71 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Tandem Diabetes Care
TNDM
|
-1.25 B | $ 24.02 | -2.02 % | $ 1.63 B | USA |
 |
InspireMD
NSPR
|
-302 M | $ 1.76 | -0.56 % | $ 113 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 11.33 | -1.31 % | $ 1.53 B | USA |
 |
Penumbra
PEN
|
238 M | $ 336.05 | 0.54 % | $ 13.1 B | USA |
 |
Myomo
MYO
|
-119 M | $ 0.69 | -0.33 % | $ 28.9 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-374 M | $ 2.28 | -5.0 % | $ 134 M | Israel |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.7 | -5.37 % | $ 138 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 16.22 | 1.95 % | $ 381 M | USA |
 |
Outset Medical
OM
|
-1.17 B | $ 3.49 | -1.27 % | $ 53.1 K | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 51.29 | -1.52 % | $ 1.51 B | USA |
 |
Pulmonx Corporation
LUNG
|
-522 M | $ 1.29 | -1.53 % | $ 52.5 M | USA |